Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1223 of 5804
-
Gentle brain zaps may boost speech recovery after stroke
Symptom relief Recruiting nowThis study aims to investigate the efficacy of transcranial direct current stimulation (tDCS) in patients with post-stroke aphasia (PSA) and to explore its potential neural mechanisms. The study will recruit PSA patients and provide them with 14 tDCS sessions over 7 days, along w…
Phase: NA • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Can a mindfulness program curb youth suicide? new study aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two stru…
Phase: NA • Sponsor: Ajou University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New hope for babies with rare dwarfism: daily shot may boost growth
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period.
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Special baby formula may boost growth in heart defect infants
Disease control Recruiting nowThis study is testing whether a special formula called Fortini, which is a high-calorie, low osmolality formula can help high-risk babies with single ventricle physiology grow better after their initial Stage 1 surgical palliation. These babies often struggle to gain weight, whic…
Phase: NA • Sponsor: Driscoll Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Experimental drug triapine paired with radiation targets recurrent brain cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or astrocytoma that has come back after a period of improvement (recurrent). Triapine may stop the growth of tumor cells by bl…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of AOH1996 begins
Disease control TerminatedThis phase 1 trial tests safety, side effects, and best dose of AOH1996 for the treatment of patients with acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or AML that has not responded to previous treatment (refractory). AOH1996 is in a cl…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill could help ITP patients who failed other treatments
Disease control Recruiting nowThe purpose of the phase 1 part of this study was to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be …
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New heart valve study aims to fix leaky valve without Open-Heart surgery
Disease control Recruiting nowThe Harmony Transcatheter Pulmonary Valve (TPV) System is indicated for use in the management of pediatric and adult congenital heart disease patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regu…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New epilepsy drug SPN-817 put to the test in Year-Long safety study
Disease control Recruiting nowThis is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New 'Tri-Specific' antibody takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe investigational drug, SOA101, is a nanobody-based trispecific antibody T cell engager targeting PD-L1/HLA-G/CD3. This is a Phase I/IIa study including dose-escalation, dose optimization and dose expansion parts to exam safety, tolerability, pharmacokinetics, immunogenecity an…
Phase: PHASE1, PHASE2 • Sponsor: Shine-On Biomedical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New mapping tech aims to improve heart ablation for AFib patients
Disease control OngoingThe study is designed to collect data on the acute and long-term (1 year) safety and effectiveness outcome when an ablation procedure is performed in a commercial and standard of care setting with the FARAPULSE™ Pulsed Field Ablation System, whereby the FARAWAVE NAV Ablation cath…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a probiotic during pregnancy help babies grow stronger?
Disease control Recruiting nowBurden: Environmental Enteric Dysfunction (EED) is an enteropathic condition characterized by altered gut permeability, infiltration of immune cells and changes in villous architecture and cell differentiation. EED is a major reason of malnourishment, poor neurological developmen…
Phase: PHASE2 • Sponsor: University Ghent • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could early radiation zap away facial pain for good?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate Gamma Knife stereotactic radiosurgery (GK-SRS) as an ultra-early treatment option for trigeminal neuralgia (TN). The main questions it aims to answer are: 1. will earlier GK-SRS provide more durable pain relief compared to later GK…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New drug candidate BL-M05D1 enters early human trials for tough cancers
Disease control Recruiting nowThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a tiny implant cure your sleep apnea?
Disease control Recruiting nowThis is a study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.
Phase: NA • Sponsor: Lunair Medical • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
3D tech may sharpen heart valve placement in leaky aortic disease
Disease control ENROLLING_BY_INVITATIONThis study will evaluate the safety and efficacy of postmarket bioprosthetic aortic valve in patients with severe aortic regurgitation undergoing transapical transcatheter aortic valve replacement based on 3D simulation technology using a prospective, randomized controlled study.
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowPerformance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prosp…
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Promising enzyme therapy for kids with rare fabry disease enters key trial
Disease control Recruiting nowA Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease.
Phase: PHASE2, PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for arthritis sufferers? CIT-013 drug trial begins
Disease control Recruiting nowThe goal of this clinical trial is to learn if CIT-013 works to treat rheumatoid arthritis in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of RA patients? What medical problems do partic…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo targets Hard-to-Treat head and neck cancer
Disease control Recruiting nowThis study is a single center, non-randomized, prospective phase II clinical trial to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab in patients with with recurrent/metastatic head and neck squamous cell carcinoma failed second-line treatment. The participants w…
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC